|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36
Cancers in 185 Countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Teng Z, Han R, Huang X, Zhou J, Yang J,
Luo P and Wu M: Increase of incidence and mortality of ovarian
cancer during 2003–2012 in Jiangsu Province, China. Front Public
Health. 4:1462016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Winarto H, Welladatika A, Habiburrahman M,
Purwoto G, Kusuma F, Utami TW, Putra AD, Anggraeni T and Nuryanto
KH: Overall survival and related factors of advanced-stage
epithelial ovarian cancer patients underwent debulking surgery in
Jakarta, Indonesia: A single-center experience. Open Access Maced J
Med Sci. 10:265–280. 2022. View Article : Google Scholar
|
|
4
|
Torre LA, Trabert B, DeSantis CE, Miller
KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A and Siegel RL:
Ovarian cancer statistics, 2018. CA Cancer J Clin. 68:284–296.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aziz MF: Gynecological cancer in
Indonesia. J Gynecol Oncol. 20:8–10. 2009. View Article : Google Scholar
|
|
6
|
Devouassoux-Shisheboran M and Genestie C:
Pathobiology of ovarian carcinomas. Chin J Cancer. 34:50–55. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Beauchamp MC, Yasmeen A, Knafo A and
Gotlieb WH: Targeting insulin and insulin-like growth factor
pathways in epithelial ovarian cancer. J Oncol. 2010:2570582010.
View Article : Google Scholar
|
|
8
|
Kellenberger LD, Bruin JE, Greenaway J,
Campbell NE, Moorehead RA, Holloway AC and Petrik J: The role of
dysregulated glucose metabolism in epithelial ovarian cancer. J
Oncol. 2010:5143102010. View Article : Google Scholar
|
|
9
|
Uzunlulu M, Telci Caklili O and Oguz A:
Association between metabolic syndrome and cancer. Ann Nutr Metab.
68:173–179. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tseng YH, Ueki K, Kriauciunas KM and Kahn
CR: Differential roles of insulin receptor substrates in the
anti-apoptotic function of insulin-like growth factor-1 and
insulin. J Biol Chem. 277:31601–31611. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Djiogue S, Nwabo Kamdje AH, Vecchio L,
Kipanyula MJ, Farahna M, Aldebasi Y and Seke Etet PF: Insulin
resistance and cancer: The role of insulin and IGFs. Endocr Relat
Cancer. 20:R1–R17. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Atsumi T: Diabetes and risk of cancer.
Diabetol Int. 6:190–192. 2015. View Article : Google Scholar
|
|
13
|
Joung KH, Jeong JW and Ku BJ: The
association between type 2 diabetes mellitus and women cancer: The
epidemiological evidences and putative mechanisms. Biomed Res Int.
2015:9206182015. View Article : Google Scholar
|
|
14
|
Igwe EO, Azman A, Nordin A and Mohtarrudin
N: Association between HOMA-IR and Cancer in a Medical Centre in
Selangor, Malaysia. IJPHCS. 2:21–34. 2015.
|
|
15
|
Ekinci O, Eren T, Kurtoglu Yakici M,
Gapbarov A, Aydemir MA, Saglam ZA and Alimoglu O: Relationship
Between Metabolic Syndrome and Postmenopausal Breast Cancer. Cir
Esp (Engl Ed). 98:540–546. 2020.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun W, Lu J, Wu S, Bi Y, Mu Y, Zhao J, Liu
C, Chen L, Shi L, Li Q, et al: Association of insulin resistance
with breast, ovarian, endometrial and cervical cancers in
non-diabetic women. Am J Cancer Res. 6:2334–2344. 2016.PubMed/NCBI
|
|
17
|
Nam S, Park S, Park HS, Kim S, Kim JY and
Kim SI: Association between insulin resistance and luminal B
subtype breast cancer in postmenopausal women. Medicine
(Baltimore). 95:e28252016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gennari A, Puntoni M, Nanni O, De Censi A,
Bruzzi P, Paleari L, Freschi A, Amaducci L, Bologna A, Gianni L and
Amadori D: Impact of insulin resistance (IR) on the prognosis of
metastatic breast cancer (MBC) patients treated with first-line
chemotherapy (CT). J Clin Oncol. 32 (Suppl 15):S5142014. View Article : Google Scholar
|
|
19
|
Doğan İ, Ürün Y and Onur H: Effects of
Adjuvant Chemotherapy on Insulin Resistance in Patients with Early
Breast Cancer. Cam and Sakura Med J. 2:8–13. 2022. View Article : Google Scholar
|
|
20
|
Alan O, Akin Telli T, Aktas B, Koca S,
Ökten IN, Hasanov R, Basoglu T, Arikan R, Demircan NC, Ercelep O,
et al: Is insulin resistance a predictor for complete response in
breast cancer patients who underwent neoadjuvant treatment? World J
Surg Oncol. 18:2422020. View Article : Google Scholar
|
|
21
|
Martín-Manzo MV, Lara C, Vargas-de-Leon C,
Carrero J, Queipo G, Fonseca-Sanchez M, Mejia-Dominguez NR,
Kershenobich D, Mummidi S, Zentella-Dehesa A and Hernandez J:
Interaction of Breast Cancer and Insulin Resistance on PD1 and TIM3
Expression in Peripheral Blood CD8 T Cells. Pathol Oncol Res.
25:1233–1243. 2019. View Article : Google Scholar
|
|
22
|
Lai Y and Sun C: Association of abnormal
glucose metabolism and insulin resistance in patients with atypical
and typical endometrial cancer. Oncol Lett. 15:2173–2178. 2018.
|
|
23
|
Momenimovahed Z, Tiznobaik A, Taheri S and
Salehiniya H: Ovarian cancer in the world: Epidemiology and risk
factors. Int J Womens Health. 11:287–299. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Serin IS, Tanriverdi F, Yilmaz MO, Ozcelik
B and Unluhizarci K: Serum insulin-like growth factor (IGF)-I, IGF
binding protein (IGFBP)-3, leptin concentrations and insulin
resistance in benign and malignant epithelial ovarian tumors in
postmenopausal women. Gynecol Endocrinol. 24:117–121. 2008.
View Article : Google Scholar
|
|
25
|
Otokozawa S, Tanaka R, Akasaka H, Ito E,
Asakura S, Ohnishi H, Saito S, Miura T, Saito T and Mori M:
Associations of serum isoflavone, adiponectin and insulin levels
with risk for epithelial ovarian cancer: Results of a case-control
study. Asian Pac J Cancer Prev. 16:4987–4991. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lukanova A, Lundin E, Toniolo P, Micheli
A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V,
et al: Circulating levels of insulin-like growth factor-I and risk
of ovarian cancer. Int J Cancer. 101:549–554. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dahlan MS: Sample Size in Medical and
Health Research. 5th edition. Epidemiologi Indonesia; Jakarta:
2019, (In Indonesian).
|
|
28
|
Sharma SK, Mudgal SK, Thakur K and Gaur R:
How to calculate sample size for observational and experiential
nursing research studies? Natl J Physiol Pharm Pharmacol. 10:1–8.
2020. View Article : Google Scholar
|
|
29
|
Timmerman D, Ameye L, Fischerova D,
Epstein E, Melis GB, Guerriero S, Van Holsbeke C, Savelli L,
Fruscio R, Lissoni AA, et al: Simple ultrasound rules to
distinguish between benign and malignant adnexal masses before
surgery: Prospective validation by IOTA group. BMJ. 341:c68392010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Abramowicz JS and Timmerman D: Ovarian
mass-differentiating benign from malignant: The value of the
International Ovarian Tumor Analysis ultrasound rules. Am J Obstet
Gynecol. 217:652–660. 2017. View Article : Google Scholar
|
|
31
|
Badan Pusat Statistik/BPS-Statistics
Indonesia, . Concept of Population, Age, Marital Status, Children
Ever Born, Children Still Alive, and Place of Birth in Indonesia.
Concept. 2021.https://www.bps.go.id/subject/12/kependudukan.htmlDecember
10–2021
|
|
32
|
Mulyana W: Rural-urban linkages: Indonesia
case study. Working Group: Development with Territorial Cohesion.
Territorial Cohesion for Development Program Rimisp. 1–36.
2014.
|
|
33
|
Badan Pusat Statistik/BPS-Statistics
Indonesia, . Regulation of the Head of the Central Statistics
Agency Number 120 of 2020: Classification of Urban and Rural Areas
in Java, Indonesia [In Indonesian]. Book Chapter Java. 2nd ed. BPS;
Jakarta: pp. 1–692. 2010
|
|
34
|
Badan Pusat Statistik/BPS-Statistics
Indonesia, . Regulation of the Head of the Central Statistics
Agency Number 120 of 2020: Classification of Urban and Rural Areas
in Sumatra, Indonesia [In Indonesian]. Book Chapter Sumatera. 2nd
ed. BPS; Jakarta: pp. 1–681. 2010
|
|
35
|
Klar M, Hasenburg A, Hasanov M, Hilpert F,
Meier W, Pfisterer J, Pujade-Lauraine E, Herrstedt J, Reuss A and
du Bois A: Prognostic factors in young ovarian cancer patients: An
analysis of four prospective phase III intergroup trials of the AGO
Study Group, GINECO and NSGO. Eur J Cancer. 66:114–124. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lalrinpuii E, Bhageerathy PS, Sebastian A,
Jeyaseelan L, Vinotha Thomas, Thomas A, Chandy R and Peedicayil A:
Ovarian Cancer in Young Women. Indian J Surg Oncol. 8:540–547.
2017. View Article : Google Scholar
|
|
37
|
Encinas G, Maistro S, Pasini FS, Katayama
ML, Brentani MM, Bock GH and Folgueira MA: Somatic mutations in
breast and serous ovarian cancer young patients: A systematic
review and meta-analysis. Rev Assoc Med Bras (1992). 61:474–483.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bozas G, Dimopoulos MA, Kastritis E,
Efstathiou E, Koutsoukou V, Rodolakis A, Vlahos G, Voulgaris Z,
Papageorgiou T, Gika D, et al: Young age is associated with
favorable characteristics but is not an independent prognostic
factor in patients with epithelial ovarian cancer: A single
institution experience. Oncology. 70:265–272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Winarto H, Habiburrahman M, Dorothea M,
Wijaya A, Nuryanto KH, Kusuma F, Utami TW and Anggraeni TD:
Knowledge, attitudes, and practices among Indonesian urban
communities regarding HPV infection, cervical cancer, and HPV
vaccination. PLoS One. 17:e02661392022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
4Berek JS, Renz M, Kehoe S, Kumar L and
Friedlander M: FIGO Cancer Report 2021: Cancer of the ovary,
fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet.
155:61–85. 2021. View Article : Google Scholar
|
|
41
|
World Health Organization and
International Agency for Research on Cancer, . World Health
Organization: WHO Classification of Tumours: Female Genital
Tumours. 5th edition. WHO; Geneva, Switzerland: pp. 31–163.
2021
|
|
42
|
Matz M, Coleman MP, Sant M, Chirlaque MD,
Visser O, Gore M and Allemani C; & the CONCORD Working Group, :
The histology of ovarian cancer: Worldwide distribution and
implications for international survival comparisons (CONCORD-2).
Gynecol Oncol. 144:405–413. 2017. View Article : Google Scholar
|
|
43
|
Unger T, Borghi C, Charchar F, Khan NA,
Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS,
Tomaszewski M, et al: 2020 International Society of Hypertension
Global Hypertension Practice Guidelines. Hypertension.
75:1334–1357. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
National Health and Nutrition Examination
Survey and Center of Disease Control and Prevention, .
Anthropometry Procedures Manual CDC2. 1–65. 2007.
|
|
45
|
Lim JU, Lee JH, Kim JS, Hwang YI, Kim TH,
Lim SY, Yoo KH, Jung KS, Kim YK and Rhee CK: Comparison of World
Health Organization and Asia-Pacific body mass index
classifications in COPD patients. Int J Chron Obstruct Pulmon Dis.
12:2465–2475. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cleveland Clinic, . Fasting Blood Sugar
Test. Diagnostics & Testing; 2021, https://my.clevelandclinic.org/health/diagnostics/21952-fasting-blood-sugarDecember
10–2021
|
|
47
|
Gayoso-Diz P, Otero-González A,
Rodriguez-Alvarez MX, Gude F, García F, De Francisco A and Quintela
AG: Insulin resistance (HOMA-IR) cut-off values and the metabolic
syndrome in a general adult population: Effect of gender and age:
EPIRCE cross-sectional study. BMC Endocr Disord. 13:472013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Farahani H, Mahmoudi T, Asadi A, Nobakht
H, Dabiri R and Hamta A: Insulin Resistance and Colorectal Cancer
Risk: The Role of Elevated Plasma Resistin Levels. J Gastrointest
Cancer. 51:478–483. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gupta RK, Dholariya SJ, Kaushik S, Gupta
SK, Tripathi R and Jain SL: Hyperinsulinemia and
Hypoadiponectinemia are Associated with increased risk for
occurrence of ovarian cancer in non-diabetic women of North Indian
Population. Indian J Clin Biochem. 36:221–227. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
American Diabetes Association (ADA), .
Diagnosis of Diabetes Mellitus. ADA; Arlington, VA: 2022
|
|
51
|
Lunger F, Wildt L and Seeber B: Accurate
screening for insulin resistance in PCOS women using fasting
insulin concentrations. Gynecol Endocrinol. 29:541–544. 2013.
View Article : Google Scholar
|
|
52
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985. View Article : Google Scholar
|
|
53
|
Onishi Y, Hayashi T, Sato KK, Ogihara T,
Kuzuya N, Anai M, Tsukuda K, Boyko EJ, Fujimoto WY and Kikuchi M:
Fasting tests of insulin secretion and sensitivity predict future
prediabetes in Japanese with normal glucose tolerance. J Diabetes
Investig. 1:191–195. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yamauchi K, Sato Y, Nakasone Y and Aizawa
T: Comparison of HOMA-IR, HOMA-β% and disposition index between US
white men and Japanese men in Japan in the ERA JUMP study: Was the
calculation of disposition index legitimate? Diabetologia.
58:1679–1680. 2015. View Article : Google Scholar
|
|
55
|
Imano H, Kitamura A, Yamagishi K, Kiyama
M, Ohira T, Cui R, Umesawa M, Okada T and Iso H; CIRCS
Investigators, : Abstract P455: Insulin Resistance, Secretion and
Risk of Incident Coronary Heart Disease in Non-diabetic Japanese
Population: The Circulatory Risk in Communities Study. Circulation.
129:AP4552014. View Article : Google Scholar
|
|
56
|
Singh B and Saxena A: Surrogate markers of
insulin resistance: A review. World J Diabetes. 1:36–47. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Duncan MH, Singh BM, Wise PH, Carter G and
Alaghband-Zadeh J: A simple measure of insulin resistance. Lancet.
346:120–121. 1995. View Article : Google Scholar
|
|
58
|
Tsarouhas K, Tsitsimpikou C, Haliassos A,
Georgoulias P, Koutsioras I, Kouretas D, Kogias J, Liosis I,
Rentoukas E and Kyriakides Z: Study of insulin resistance, TNF-α,
total antioxidant capacity and lipid profile in patients with
chronic heart failure under exercise. In Vivo. 25:1031–1037.
2011.PubMed/NCBI
|
|
59
|
Farkas GJ, Gordon PS, Trewick N, Gorgey
AS, Dolbow DR, Tiozzo E, Berg AS and Gater DR Jr: Comparison of
various indices in identifying insulin resistance and diabetes in
chronic spinal cord injury. J Clin Med. 10:55912021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Gordon PS, Farkas GJ and Gater DR Jr:
Neurogenic Obesity-Induced Insulin Resistance and Type 2 Diabetes
Mellitus in Chronic Spinal Cord Injury. Top Spinal Cord Inj
Rehabil. 27:36–56. 2021. View Article : Google Scholar
|
|
61
|
Katz A, Nambi SS, Mather K, Baron AD,
Follmann DA, Sullivan G and Quon MJ: Quantitative insulin
sensitivity check index: A simple, accurate method for assessing
insulin sensitivity in humans. J Clin Endocrinol Metab.
85:2402–2410. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Matsuda M and DeFronzo RA: Insulin
sensitivity indices obtained from oral glucose tolerance testing:
Comparison with the euglycemic insulin clamp. Diabetes Care.
22:1462–1470. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Pratisthita Livy B, Purnamasari D, Rizka
A, Soewondo P, Yunir E and Tahapary DL: The Cut-off Values of
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) in
Indonesian Rural Population. Lancet Preprint. 6:7–20. 2020.
|
|
64
|
Rahman MN, Sukmawati IR, Puspitasari IM
and Fattah M: Serum free zinc as a predictor for excessive function
of pancreatic beta-cells in central-obese men. Indones Biomed J.
11:262–266. 2019. View Article : Google Scholar
|
|
65
|
AlZadjali MA, Godfrey V, Khan F, Choy A,
Doney AS, Wong AK, Petrie JR, Struthers AD and Lang CC: Insulin
resistance is highly prevalent and is associated with reduced
exercise tolerance in nondiabetic patients with heart failure. J Am
Coll Cardiol. 53:747–753. 2009. View Article : Google Scholar
|
|
66
|
Kaur N, Gitanjali, Garg R, Tapasvi C,
Chawla S and Kaur N: Correlation of Surrogate Markers of Insulin
Resistance with Fasting Insulin in Type 2 Diabetes Mellitus
Patients: A Study of Malwa Population in Punjab, India. J Lab
Physicians. 13:238–244. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Diebetes.co.uk, . Blood Sugar Converter.
Calculators and Tools. 2022.https://www.diabetes.co.uk/blood-sugar-converter.htmlApril
12–2022
|
|
68
|
Katalin C: Surrogate Measures of Insulin
Resistance in Middle-aged Non-diabetic Subjects. Acta Med
Marisiensis. 59:279–284. 2014. View Article : Google Scholar
|
|
69
|
Burzawa JK, Schmeler KM, Soliman PT, Meyer
LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM,
Tortolero-Luna G, Urbauer DL, et al: Prospective evaluation of
insulin resistance among endometrial cancer patients. Am J Obstet
Gynecol. 204:355.e1–7. 2011. View Article : Google Scholar
|
|
70
|
von Elm E, Altman DG, Egger M, Pocock SJ,
Gøtzsche PC and Vandenbroucke JP: Strengthening the reporting of
observational studies in epidemiology (STROBE) statement:
guidelines for reporting observational studies. BMJ. 335:806
LP–808. 2007. View Article : Google Scholar
|
|
71
|
Statistic Tutor: Spearman's correlation,
2021. http://www.statstutor.ac.uk/resources/uploaded/spearmans.pdfDecember
10–2021
|
|
72
|
Beavis AL, Smith AJ and Fader AN:
Lifestyle changes and the risk of developing endometrial and
ovarian cancers: Opportunities for prevention and management. Int J
Womens Health. 8:151–167. 2016.PubMed/NCBI
|
|
73
|
Szpurek D, Moszynski R, Szubert S and
Sajdak S: Urban and rural differences in characteristics of ovarian
cancer patients. Ann Agric Environ Med. 20:390–394. 2013.PubMed/NCBI
|
|
74
|
Saccò M, Meschi M, Regolisti G, Detrenis
S, Bianchi L, Bertorelli M, Pioli S, Magnano A, Spagnoli F, Giuri
PG, et al: The relationship between blood pressure and pain. J Clin
Hypertens (Greenwich). 15:600–605. 2013. View Article : Google Scholar
|
|
75
|
El-Atat FA, Stas SN, McFarlane SI and
Sowers JR: The relationship between hyperinsulinemia, hypertension
and progressive renal disease. J Am Soc Nephrol. 15:2816–2827.
2004. View Article : Google Scholar
|
|
76
|
Pérez-Pérez A, Sánchez-Jiménez F,
Vilariño-García T and Sánchez-Margalet V: Role of Leptin in
Inflammation and Vice Versa. Int J Mol Sci. 21:2020. View Article : Google Scholar
|
|
77
|
Orgel E and Mittelman SD: The links
between insulin resistance, diabetes, and cancer. Curr Diab Rep.
13:213–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Kim SI, Kim HS, Kim TH, Suh DH, Kin K, No
JH, Chung HH, Kim YB and Song YS: Impact of underweight after
treatment on prognosis of advanced-stage ovarian cancer. J Immunol
Res. 2014.1–8. 2014. View Article : Google Scholar
|
|
79
|
Wright JD, Powell MA, Mutch DG, Rader JS,
Gibb RK, Gao F and Herzog TJ: Relationship of ovarian neoplasms and
body mass index. J Reprod Med. 50:595–602. 2005.PubMed/NCBI
|
|
80
|
Leitzmann MF, Koebnick C, Danforth KN, et
al: Body mass index and risk of ovarian cancer. Cancer.
115:812–822. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Hernandez AV, Guarnizo M, Miranda Y,
Pasupuleti V, Deshpande A, Paico S, Lenti H, Ganoza S, Montalvo L,
Thota P and Lazaro H: Association between insulin resistance and
breast carcinoma: A systematic review and meta-analysis. PLoS One.
9:e993172014. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kundaktepe BP, Durmus S, Cengiz M,
Kundaktepe FO, Sozer V, Papila C, Gelisgen R and Uzun H: The
significance of insulin resistance in nondiabetic breast cancer
patients. J Endocrinol Metab. 11:42–48. 2021. View Article : Google Scholar
|
|
83
|
Gómez JM, Maravall FJ, Gómez N, Navarro
MA, Casamitjana R and Soler J: Interactions between serum leptin,
the insulin-like growth factor-I system, and sex, age,
anthropometric and body composition variables in a healthy
population randomly selected. Clin Endocrinol (Oxf). 58:213–219.
2003. View Article : Google Scholar
|
|
84
|
Bjørge T, Lukanova A, Tretli S, Manjer J,
Ulmer H, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, et al:
Metabolic risk factors and ovarian cancer in the Metabolic Syndrome
and Cancer project. Int J Epidemiol. 40:1667–1677. 2011. View Article : Google Scholar
|
|
85
|
Craig ER, Londoño AI, Norian LA and Arend
RC: Metabolic risk factors and mechanisms of disease in epithelial
ovarian cancer: A review. Gynecol Oncol. 143:674–683. 2016.
View Article : Google Scholar
|
|
86
|
Khanlarkhani N, Azizi E, Amidi F,
Khodarahmian M, Salehi E, Pazhohan A, Farhood B, Mortezae K,
Goradel NH and Nashtaei MS: Metabolic risk factors of ovarian
cancer: A review. JBRA Assist Reprod. 26:335–347. 2022.PubMed/NCBI
|
|
87
|
Dixon SC, Nagle CM, Thrift AP, Pharoah PD,
Pearce CL, Zheng W, Painter JN; AOCS Group & Australian Cancer
Study (Ovarian Cancer), ; Chenevix-Trench G, Fasching PA, et al:
Adult body mass index and risk of ovarian cancer by subtype: A
Mendelian randomization study. Int J Epidemiol. 45:884–895. 2016.
View Article : Google Scholar
|
|
88
|
Zeleznik OA, Eliassen AH, Kraft P, Poole
EM, Rosner BA, Jeanfavre S, Deik AA, Bullock K, Hitchcock DS,
Avila-Pacheco J, et al: A prospective analysis of circulating
plasma metabolites Associated with ovarian cancer risk. Cancer Res.
80:1357–1367. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Lee S, Choi S, Kim HJ, Chung YS, Lee KW,
Lee HC, Huh KB and Kim DJ: Cutoff values of surrogate measures of
insulin resistance for metabolic syndrome in Korean non-diabetic
adults. J Korean Med Sci. 21:695–700. 2006. View Article : Google Scholar
|
|
90
|
Bonora E, Targher G, Alberiche M,
Bonadonna RC, Saggiani F, Zenere MB, Monauni T and Muggeo M:
Homeostasis model assessment closely mirrors the glucose clamp
technique in the assessment of insulin sensitivity: Studies in
subjects with various degrees of glucose tolerance and insulin
sensitivity. Diabetes Care. 23:57–63. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Robbins DC, Andersen L, Bowsher R, Chance
R, Dinesen B, Frank B, Gingerich R, Goldstein D, Widemeyer HM,
Haffner S, et al: Report of the American Diabetes Association's
Task Force on standardization of the insulin assay. Diabetes.
45:242–256. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Mack R, Skurnick B, Sterling-Jean Y,
Pedra-Nobre M and Bigg D: Fasting insulin levels as a measure of
insulin resistance in American blacks. J Med. 34:31–38.
2003.PubMed/NCBI
|
|
93
|
Yeni-Komshian H, Carantoni M, Abbasi F and
Reaven GM: Relationship between several surrogate estimates of
insulin resistance and quantification of insulin-mediated glucose
disposal in 490 healthy nondiabetic volunteers. Diabetes Care.
23:171–175. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Buchanan TA, Watanabe RM and Xiang AH:
Limitations in surrogate measures of insulin resistance. J Clin
Endocrinol Metab. 95:4874–4876. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Haffner SM, Miettinen H and Stern MP: The
homeostasis model in the San Antonio Heart Study. Diabetes Care.
20:1087–1092. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Legro RS, Finegood D and Dunaif A: A
fasting glucose to insulin ratio is a useful measure of insulin
sensitivity in women with polycystic ovary syndrome. J Clin
Endocrinol Metab. 83:2694–2698. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Jørgensen SW, Hjort L, Gillberg L,
Justesen L, Madsbad S, Brøns C and Vaag AA: Impact of prolonged
fasting on insulin secretion, insulin action, and hepatic versus
whole body insulin secretion disposition indices in healthy young
males. Am J Physiol Endocrinol Metab. 320:E281–E290. 2021.
View Article : Google Scholar
|
|
98
|
Habib SS, Eshki A, AlTassan B, Fatani D,
Helmi H and AlSaif S: Relationship of serum novel adipokine
chemerin levels with body composition, insulin resistance,
dyslipidemia and diabesity in Saudi women. Eur Rev Med Pharmacol
Sci. 21:1296–1302. 2017.
|
|
99
|
Pavelić K, Slijepcević M, Pavelić J, Ivić
J, Audy-Jurković S, Pavelić ZP and Boranić M: Growth and treatment
of Ehrlich tumor in mice with alloxan-induced diabetes. Cancer Res.
39:1807–1813. 1979.
|
|
100
|
Gates JR, Parpia B, Campbell TC and Chen
J: Evaluation of the FIRI (Fasting Insulin Resistance Index) and
selected plasma parameters associated with insulin resistance as
predictors of cardiovascular mortality in rural Chinese women. Asia
Pac J Clin Nutr. 6:200–202. 1997.PubMed/NCBI
|
|
101
|
Mather KJ, Hunt AE, Steinberg HO, Paradisi
G, Hook G, Katz A, Quon MJ and Baron AD: Repeatability
characteristics of simple indices of insulin resistance:
Implications for research applications. J Clin Endocrinol Metab.
86:5457–5464. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Chen H, Sullivan G, Yue LQ, Katz A and
Quon MJ: QUICKI is a useful index of insulin sensitivity in
subjects with hypertension. Am J Physiol Endocrinol Metab.
284:E804–E812. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Hettihewa LM, Palangasinghe S, Jayasinghe
SS, Gunasekara SW and Weerarathna TP: Comparison of insulin
resistance by indirect methods-HOMA, QUICKI and McAuley-With
fasting insulin in patients with type 2 diabetes in Galle, Sri
Lanka: A pilot study. Online J Health Allied Sci. 5:1–8. 2006.
|
|
104
|
Scoppola A, Strigari L, Barnabei A,
Petasecca P, De Galitiis F, Fulgenzi CAM, Roselli M, De Lorenzo A,
Di Renzo L, Marchetti P and Torino F: Insulin resistance as a risk
factor for cutaneous melanoma. A case control study and
risk-assessment nomograms. Front Endocrinol (Lausanne). 10:7572019.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Rutter MK, Wilson PWF, Sullivan LM, Fox
CS, D'Agostino RB Sr and Meigs JB: Use of alternative thresholds
defining insulin resistance to predict incident type 2 diabetes
mellitus and cardiovascular disease. Circulation. 117:1003–1009.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Conwell LS, Trost SG, Brown WJ and Batch
JA: Indexes of insulin resistance and secretion in obese children
and adolescents: A validation study. Diabetes Care. 27:314–319.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Garg MK, Tandon N, Marwaha RK and Singh Y:
Evaluation of surrogate markers for insulin resistance for defining
metabolic syndrome in urban Indian adolescents. Indian Pediatr.
51:279–284. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Rudvik A and Månsson M: Evaluation of
surrogate measures of insulin sensitivity-correlation with gold
standard is not enough. BMC Med Res Methodol. 18:642018. View Article : Google Scholar
|
|
109
|
Coppola D, Saunders B, Fu L, Mao W and
Nicosia SV: The insulin-like growth factor 1 receptor induces
transformation and tumorigenicity of ovarian mesothelial cells and
down-regulates their Fas-receptor expression. Cancer Res.
59:3264–3270. 1999.PubMed/NCBI
|
|
110
|
Karasik A, Menczer J, Pariente C and
Kanety H: Insulin-like growth factor-I (IGF-I) and IGF-binding
protein-2 are increased in cyst fluids of epithelial ovarian
cancer. J Clin Endocrinol Metab. 78:271–276. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Holly J: Insulin-like growth factor-1 and
risk of breast cancer. Lancet. 352:13881998. View Article : Google Scholar
|
|
112
|
D'Esposito V, Passaretti F, Hammarstedt A,
Liguoro D, Terracciano D, Molea G, Canta L, Miele C, Smith U,
Beguinot F and Formisano P: Adipocyte-released insulin-like growth
factor-1 is regulated by glucose and fatty acids and controls
breast cancer cell growth in vitro. Diabetologia. 55:2811–2822.
2012. View Article : Google Scholar
|
|
113
|
Sanchez-Garrido MA and Tena-Sempere M:
Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role
of androgen excess and potential therapeutic strategies. Mol Metab.
35:2020. View Article : Google Scholar
|
|
114
|
Takemura Y, Ouchi N, Shibata R, Aprahamian
T, Kirber MT, Summer RS, Kihara S and Walsh K: Adiponectin
modulates inflammatory reactions via calreticulin
receptor-dependent clearance of early apoptotic bodies. J Clin
Invest. 117:375–386. 2007. View Article : Google Scholar
|
|
115
|
Kalli KR, Falowo OI, Bale LK, Zschunke MA,
Roche PC and Conover CA: Functional insulin receptors on human
epithelial ovarian carcinoma cells: Implications for IGF-II
mitogenic signaling. Endocrinology. 143:3259–3267. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Lutz AM, Ray P, Willmann JK, Drescher C
and Gambhir SS: 2-Deoxy-2-[F-18]fluoro-D-glucose accumulation in
ovarian carcinoma cell lines. Mol Imaging Biol. 9:260–266. 2007.
View Article : Google Scholar
|
|
117
|
Shibata K, Kajiyama H, Mizokami Y, Ino K,
Nomura S, Mizutani S, Terauchi M and Kikkawa F: Placental leucine
aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression
in benign, borderline, and malignant ovarian epithelia. Gynecol
Oncol. 98:11–18. 2005. View Article : Google Scholar
|
|
118
|
Tsukioka M, Matsumoto Y, Noriyuki M,
Yoshida C, Nobeyama H, Yoshida H, Yasui T, Sumi T, Honda K and
Ishiko O: Expression of glucose transporters in epithelial ovarian
carcinoma: Correlation with clinical characteristics and tumor
angiogenesis. Oncol Rep. 18:361–367. 2007.PubMed/NCBI
|
|
119
|
Sheetz MJ and King GL: Molecular
understanding of hyperglycemia's adverse effects for diabetic
complications. JAMA. 288:2579–2588. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Yamagishi S, Nakamura K, Inoue H, Kikuchi
S and Takeuchi M: Possible participation of advanced glycation end
products in the pathogenesis of colorectal cancer in diabetic
patients. Med Hypotheses. 64:1208–1210. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Taguchi A, Blood DC, del Toro G, Canet A,
Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, et al: Blockade of
RAGE-amphoterin signalling suppresses tumour growth and metastases.
Nature. 405:354–360. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Ness RB, Grisso JA, Cottreau C, Klapper J,
Vergona R, Wheeler JE, Morgan M and Schlesselman JJ: Factors
related to inflammation of the ovarian epithelium and risk of
ovarian cancer. Epidemiology. 11:111–117. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Benjamin LE: Glucose, VEGF-A, and diabetic
complications. Am J Pathol. 158:1181–1184. 2001. View Article : Google Scholar
|
|
124
|
Wang M, Cheng N, Zheng S, Wang D, Hu X,
Ren X, Pei H, Ma H, Mu H and Bai Y: Metabolic syndrome and the risk
of breast cancer among postmenopausal women in North-West China.
Climacteric. 18:852–858. 2015. View Article : Google Scholar
|
|
125
|
DeFronzo RA, Tobin JD and Andres R:
Glucose clamp technique: A method for quantifying insulin secretion
and resistance. Am J Physiol. 237:E214–E223. 1979.
|
|
126
|
Alberti KG and Zimmet PZ: Definition,
diagnosis and classification of diabetes mellitus and its
complications. Part 1: Diagnosis and classification of diabetes
mellitus provisional report of a WHO consultation. Diabet Med.
15:539–553. 1998. View Article : Google Scholar : PubMed/NCBI
|
